AstraZeneca China Chief Under Investigation
AstraZeneca's China President Leon Wang is reportedly under investigation and is cooperating with Chinese authorities. The company has assured that its operations in China will continue under the leadership of the current General Manager. Details on Wang's status remain undisclosed.
AstraZeneca confirmed on Wednesday that Leon Wang, the company's China President, is currently under investigation. Wang is said to be cooperating with Chinese authorities.
The pharmaceutical giant stated that its China operations are continuing without interruption, now led by the current General Manager of AstraZeneca China. The company provided no further information on whether Wang is in government custody.
Inquiries about Wang's location were met with a company spokesperson's confirmation of the investigation, but no additional comments were made.
ALSO READ
-
WTO Sets Up Panel on EU Carbon Border Rules as Russia Challenges Restrictions
-
WHO Brings Global Experts Together to Strengthen Herbal Medicine Quality and Safety
-
Human Cost of Faster Work: Chinese Employees Weigh AI’s Promise Against Pay Fears
-
China's August Disasters Yield $5.38 Billion in Losses
-
China Strengthens Military Surveillance in Djibouti
Google News